Clinical Trials Logo
  1. Home
  2. Refractory Glaucoma
  3. NCT00971061

Ahmed Glaucoma Valve and Single-Plate Molteno Implants in Treatment of Refractory Glaucoma

Refractory Glaucoma Clinical Trial

Clinical Trial Summary

The purpose of this study is to investigate the efficacy and safety of the Ahmed valve implant (AVI) and the Molteno single-plate implant (MSPI) in eyes with refractory glaucoma during a follow-up period of 24 months.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00971061
Study type Interventional
Source Vanak Eye Surgery Center
Contact
Status Completed
Phase Phase 3
Start date January 2003
Completion date August 2005
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT01128699 - Ahmed Valve Glaucoma Implant With Adjunctive Subconjunctival Bevacizumab in Refractory Glaucoma Phase 3
Completed NCT05521334 - MicroPulse Transscleral Laser Cyclophotocoagulation With the Zig Zag Mode in Glaucoma. N/A
Recruiting NCT00349414 - Safety Study of Conventional Versus Micropulse Transscleral Cyclophotocoagulation in Treating End-Stage Glaucoma Phase 1/Phase 2
Recruiting NCT04921098 - CPC in Adult Refractory Glaucoma N/A
Completed NCT01404364 - Use of Intravitreal Triamcinolone and Retrobulbar Chlorpromazine as Alternatives to the Management of Painful Blind Eye N/A
Not yet recruiting NCT05230355 - Comparison Between Two Techniques of Subthreshold Diode Laser Cyclophotocoagulation in Refractory Glaucoma N/A
Completed NCT04303897 - Real-world Evidence Study of XEN in Chinese Patients With Refractory Glaucoma
Recruiting NCT00893490 - Ahmed Glaucoma Valve Alone, With Amniotic Membrane or With Mitomycin C (MMC) for Treatment of Refractory Glaucoma Phase 1